Manish Arora, LinusBio co-founder and CEO (Mount Sinai via YouTube)
LinusBio secures Series A for diagnostic platform that uses a single strand of hair
LinusBio, a Mount Sinai spinoff starting out focused on neurological disorders like autism, announced Thursday it raised $16 million in Series A funding.
Proceeds will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.